retatrutide dementia Demand for Unapproved Weight-Loss Drug Surges on Social Media Retatrutide the wonder drug: What's
Description
GLP-1 addressable market

Whats driving the trend: Cost-related insurance barriers and patients feeling that theyve lost enough weight are primary factors limiting long-term GLP-1 adherence

Nausea and Queasiness Nausea is the most frequently cited side effect

Hence, the molecular mechanisms linking metformin exposure to increased circulating levels of GLP-1 require further study

Rights and permissions About this article Cite this article Holt, R.I.G., DeVries, J.H., Hess-Fischl, A

Also approved to reduce cardiovascular risk